RxDoctor Payments Data

China Cox, MD

Adult Medicine · Arden, NCNPI 1538690862

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 11 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 9 manufacturers, the largest accounting for just 19.4% — the pattern of someone who eats at a lot of different presentations.

$222in general payments, 2019–2025

Across 11 payments — averaging $20.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • GSK$43
  • Takeda Pharmaceuticals U.S.A., Inc.$37
  • Medtronic$28
  • AbbVie$24
  • Averitas Pharma Inc.$23
  • Novo Nordisk$18
  • plus $49 from 3 others

What the payments were for

  • Food & beverage$222100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$222 in reported general payments places this provider in the 55th percentile of 25 adult medicine providers in North Carolina.

See all adult medicine providers in North Carolina

Medicare billing

Part B allowed, 2024
$59,206
Medicare patients
185
Services billed
1,317

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban18$19,185
OzempicSemaglutide16$16,362
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen30$781
Tramadol Hcl41$599
Levothyroxine Sodium56$541
Oxycodone Hcl31$479
Omeprazole27$469
Fluoxetine Hcl15$336
Albuterol Sulfate HfaAlbuterol Sulfate11$321
Gabapentin23$273
Atorvastatin Calcium57$260
Rosuvastatin Calcium28$210
Amlodipine Besylate31$174
Metformin Hcl16$171
Sumatriptan Succinate13$166

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$14$19,18518 claims
Novo NordiskOzempic$18$16,36216 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 25 adult medicine providers in North Carolina.

Other adult medicine in Arden

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →